Author:
Sompolinsky David,Nitzan Yeshayahu,Tetry Shaul,Wolk Moshe,Vulikh Israel,Kerrn Mette Barendorff,Sandvang Dorthe,Hershkovits Gitit,Katcoff Don J.
Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)
Reference10 articles.
1. Sturenburg, E. & Mack, D. (2003). Extended-spectrum β-lactamases: implications for the clinical microbiology laboratory, therapy, and infection control. Journal of Infection47, 273–95.
2. Gniadkowski, M. (2001). Evolution and epidemiology of extended-spectrum β-lactamases (ESBLs) and ESBL-producing microorganisms. Clinical Microbiology and Infection7, 597–608.
3. Borer, A., Gilad, J., Menashe, G. et al. (2002). Extended-spectrum β-lactamase-producing Enterobacteriaceae strains in community-acquired bacteremia in Southern Israel. Medical Science Monitor8, CR44–7.
4. Navon-Venezia, S., Hammer-Munz, O., Schwartz, D. et al. (2003). Occurrence and phenotypic characteristics of extended-spectrum β-lactamases among members of the family Enterobacteriaceae at the Tel-Aviv Medical Center (Israel) and evaluation of diagnostic tests. Journal of Clinical Microbiology41, 155–8.
5. Wolk, M., Valinsky, L., Sompolinsky, D. et al. (2004). Endemic occurrence of infections by multidrug-resistant Escherichia coli of four unique serotypes in the elderly population of Israel. FEMS Microbiology Letters, 239, 249–54.
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献